These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32618703)

  • 1. Histopathological Spectrum and Immunophenotypic Characterization of Symmetrical Drug-Related Intertriginous and Flexural Exanthema.
    Muresan AM; Metze D; Böer-Auer A; Braun SA
    Am J Dermatopathol; 2021 Feb; 43(2):103-111. PubMed ID: 32618703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature.
    Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP
    J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole.
    Şikar Aktürk A; Bayramgürler D; Salman S; Yıldız KD; Odyakmaz Demirsoy E
    Cutan Ocul Toxicol; 2014 Dec; 33(4):337-8. PubMed ID: 24938451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions.
    Yawalkar N; Egli F; Hari Y; Nievergelt H; Braathen LR; Pichler WJ
    Clin Exp Allergy; 2000 Jun; 30(6):847-55. PubMed ID: 10848903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic Characterization of Mogamulizumab-associated Rash.
    Wang JY; Hirotsu KE; Neal TM; Raghavan SS; Kwong BY; Khodadoust MS; Brown RA; Novoa RA; Kim YH; Rieger KE
    Am J Surg Pathol; 2020 Dec; 44(12):1666-1676. PubMed ID: 32976123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide.
    Ferreira O; Mota A; Morais P; Cunha AP; Azevedo F
    Cutan Ocul Toxicol; 2010 Dec; 29(4):293-5. PubMed ID: 20522001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib.
    Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M
    J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of T-Helper Immune Phenotype in Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Endorses a Delayed-Type Hypersensitivity Reaction.
    Chaudet KM; Russell-Goldman E; Horn TD; Schuler AM; Chan MP; Nazarian RM
    Am J Dermatopathol; 2024 Feb; 46(2):71-78. PubMed ID: 38133537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological and immunohistochemical features of drug-induced exanthems.
    Lisi P; Pelliccia S; Bellini V
    G Ital Dermatol Venereol; 2014 Apr; 149(2):237-41. PubMed ID: 24819645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic features of exanthematous drug eruptions of the macular and papular type.
    Naim M; Weyers W; Metze D
    Am J Dermatopathol; 2011 Oct; 33(7):695-704. PubMed ID: 21785331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Cabrera Hernandez V; Gonzalez Afonso M; Callero Viera A; Martin-Fernandez Martin L
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31377719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
    Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
    Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
    Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
    Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical drug-related intertriginous and flexural exanthema.
    Tan SC; Tan JW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):313-8. PubMed ID: 21659857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
    [No Abstract]   [Full Text] [Related]  

  • 18. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
    Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
    Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review.
    Keshavamurthy C; Fibeger E; Virata A; Bansal P
    ARP Rheumatol; 2022; 1(4):322-327. PubMed ID: 36617314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
    Yang SY; Lan CC; Hu SC
    Int J Dermatol; 2017 May; 56(5):571-572. PubMed ID: 28217835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.